世界の組換えDNA（rDNA）技術市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Recombinant DNA (rDNA) Technology Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4796 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、組換えDNA（rDNA）技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（発現システム、クローニングベクター）、用途別市場規模（バイオテクノロジー・製薬会社、学術・政府研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・組換えDNA（rDNA）技術の市場動向 ・企業の競争状況、市場シェア ・組換えDNA（rDNA）技術の種類別市場規模と予測2016-2027（発現システム、クローニングベクター） ・組換えDNA（rDNA）技術の用途別市場規模と予測2016-2027（バイオテクノロジー・製薬会社、学術・政府研究所、その他） ・組換えDNA（rDNA）技術の北米市場規模2016-2027（アメリカ、カナダ） ・組換えDNA（rDNA）技術の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・組換えDNA（rDNA）技術のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・組換えDNA（rDNA）技術の中南米市場規模2016-2027（メキシコ、ブラジル） ・組換えDNA（rDNA）技術の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche Ltd (Genentech, Inc)、Profacgen、Amgen Inc、Novartis AG、GenScript、Pfizer Inc、Novo Nordisk A/S、Eli Lilly and Company、Sanofi、Biocon、GlaxoSmithKline plc、New England Biolabs.、Cibus、Monsanto Company、Horizon Discovery Group PLC） ・結論

Market Analysis and Insights: Global Recombinant DNA (rDNA) Technology Market
The global Recombinant DNA (rDNA) Technology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant DNA (rDNA) Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant DNA (rDNA) Technology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant DNA (rDNA) Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant DNA (rDNA) Technology market.

Global Recombinant DNA (rDNA) Technology Scope and Market Size
Recombinant DNA (rDNA) Technology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant DNA (rDNA) Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Expression System
Cloning Vector

Segment by Application
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Profacgen
Amgen Inc
Novartis AG
GenScript
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Biocon
GlaxoSmithKline plc
New England Biolabs.
Cibus
Monsanto Company
Horizon Discovery Group PLC

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Expression System
1.2.3 Cloning Vector
1.3 Market by Application
1.3.1 Global Recombinant DNA (rDNA) Technology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic and Government Research Institutes
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Recombinant DNA (rDNA) Technology Market Perspective (2016-2027)
2.2 Recombinant DNA (rDNA) Technology Growth Trends by Regions
2.2.1 Recombinant DNA (rDNA) Technology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Recombinant DNA (rDNA) Technology Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2022-2027)
2.3 Recombinant DNA (rDNA) Technology Industry Dynamic
2.3.1 Recombinant DNA (rDNA) Technology Market Trends
2.3.2 Recombinant DNA (rDNA) Technology Market Drivers
2.3.3 Recombinant DNA (rDNA) Technology Market Challenges
2.3.4 Recombinant DNA (rDNA) Technology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue
3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2016-2021)
3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2016-2021)
3.2 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue
3.4 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2020
3.5 Recombinant DNA (rDNA) Technology Key Players Head office and Area Served
3.6 Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
3.7 Date of Enter into Recombinant DNA (rDNA) Technology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant DNA (rDNA) Technology Breakdown Data by Type
4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Type (2016-2021)
4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2022-2027)

5 Recombinant DNA (rDNA) Technology Breakdown Data by Application
5.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Application (2016-2021)
5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Recombinant DNA (rDNA) Technology Market Size (2016-2027)
6.2 North America Recombinant DNA (rDNA) Technology Market Size by Type
6.2.1 North America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021)
6.2.2 North America Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027)
6.2.3 North America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2027)
6.3 North America Recombinant DNA (rDNA) Technology Market Size by Application
6.3.1 North America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021)
6.3.2 North America Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027)
6.3.3 North America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2027)
6.4 North America Recombinant DNA (rDNA) Technology Market Size by Country
6.4.1 North America Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021)
6.4.2 North America Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2016-2027)
7.2 Europe Recombinant DNA (rDNA) Technology Market Size by Type
7.2.1 Europe Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021)
7.2.2 Europe Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027)
7.2.3 Europe Recombinant DNA (rDNA) Technology Market Size by Type (2016-2027)
7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Application
7.3.1 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021)
7.3.2 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027)
7.3.3 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2016-2027)
7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Country
7.4.1 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021)
7.4.2 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size (2016-2027)
8.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type
8.2.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type (2016-2027)
8.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application
8.3.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application (2016-2027)
8.4 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region
8.4.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Recombinant DNA (rDNA) Technology Market Size (2016-2027)
9.2 Latin America Recombinant DNA (rDNA) Technology Market Size by Type
9.2.1 Latin America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021)
9.2.2 Latin America Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027)
9.2.3 Latin America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2027)
9.3 Latin America Recombinant DNA (rDNA) Technology Market Size by Application
9.3.1 Latin America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021)
9.3.2 Latin America Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027)
9.3.3 Latin America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2027)
9.4 Latin America Recombinant DNA (rDNA) Technology Market Size by Country
9.4.1 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021)
9.4.2 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size (2016-2027)
10.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type
10.2.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type (2016-2027)
10.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application
10.3.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application (2016-2027)
10.4 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country
10.4.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
11.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
11.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
11.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction
11.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
11.2 Profacgen
11.2.1 Profacgen Company Details
11.2.2 Profacgen Business Overview
11.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction
11.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.2.5 Profacgen Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction
11.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.3.5 Amgen Inc Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction
11.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 GenScript
11.5.1 GenScript Company Details
11.5.2 GenScript Business Overview
11.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction
11.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.5.5 GenScript Recent Development
11.6 Pfizer Inc
11.6.1 Pfizer Inc Company Details
11.6.2 Pfizer Inc Business Overview
11.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction
11.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.6.5 Pfizer Inc Recent Development
11.7 Novo Nordisk A/S
11.7.1 Novo Nordisk A/S Company Details
11.7.2 Novo Nordisk A/S Business Overview
11.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction
11.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.7.5 Novo Nordisk A/S Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction
11.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.8.5 Eli Lilly and Company Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction
11.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Biocon
11.10.1 Biocon Company Details
11.10.2 Biocon Business Overview
11.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction
11.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.10.5 Biocon Recent Development
11.11 GlaxoSmithKline plc
11.11.1 GlaxoSmithKline plc Company Details
11.11.2 GlaxoSmithKline plc Business Overview
11.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction
11.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.11.5 GlaxoSmithKline plc Recent Development
11.12 New England Biolabs.
11.12.1 New England Biolabs. Company Details
11.12.2 New England Biolabs. Business Overview
11.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction
11.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.12.5 New England Biolabs. Recent Development
11.13 Cibus
11.13.1 Cibus Company Details
11.13.2 Cibus Business Overview
11.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction
11.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.13.5 Cibus Recent Development
11.14 Monsanto Company
11.14.1 Monsanto Company Company Details
11.14.2 Monsanto Company Business Overview
11.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction
11.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.14.5 Monsanto Company Recent Development
11.15 Horizon Discovery Group PLC
11.15.1 Horizon Discovery Group PLC Company Details
11.15.2 Horizon Discovery Group PLC Business Overview
11.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction
11.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.15.5 Horizon Discovery Group PLC Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Expression System
Table 3. Key Players of Cloning Vector
Table 4. Global Recombinant DNA (rDNA) Technology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Recombinant DNA (rDNA) Technology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Recombinant DNA (rDNA) Technology Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2016-2021)
Table 8. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2022-2027)
Table 10. Recombinant DNA (rDNA) Technology Market Trends
Table 11. Recombinant DNA (rDNA) Technology Market Drivers
Table 12. Recombinant DNA (rDNA) Technology Market Challenges
Table 13. Recombinant DNA (rDNA) Technology Market Restraints
Table 14. Global Recombinant DNA (rDNA) Technology Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Recombinant DNA (rDNA) Technology Market Share by Players (2016-2021)
Table 16. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2020)
Table 17. Ranking of Global Top Recombinant DNA (rDNA) Technology Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Recombinant DNA (rDNA) Technology Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
Table 21. Date of Enter into Recombinant DNA (rDNA) Technology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2016-2021)
Table 25. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Recombinant DNA (rDNA) Technology Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2016-2021)
Table 29. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 61. F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
Table 62. F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
Table 63. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Product
Table 64. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 65. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
Table 66. Profacgen Company Details
Table 67. Profacgen Business Overview
Table 68. Profacgen Recombinant DNA (rDNA) Technology Product
Table 69. Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 70. Profacgen Recent Development
Table 71. Amgen Inc Company Details
Table 72. Amgen Inc Business Overview
Table 73. Amgen Inc Recombinant DNA (rDNA) Technology Product
Table 74. Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 75. Amgen Inc Recent Development
Table 76. Novartis AG Company Details
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Recombinant DNA (rDNA) Technology Product
Table 79. Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 80. Novartis AG Recent Development
Table 81. GenScript Company Details
Table 82. GenScript Business Overview
Table 83. GenScript Recombinant DNA (rDNA) Technology Product
Table 84. GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 85. GenScript Recent Development
Table 86. Pfizer Inc Company Details
Table 87. Pfizer Inc Business Overview
Table 88. Pfizer Inc Recombinant DNA (rDNA) Technology Product
Table 89. Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 90. Pfizer Inc Recent Development
Table 91. Novo Nordisk A/S Company Details
Table 92. Novo Nordisk A/S Business Overview
Table 93. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Product
Table 94. Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 95. Novo Nordisk A/S Recent Development
Table 96. Eli Lilly and Company Company Details
Table 97. Eli Lilly and Company Business Overview
Table 98. Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 99. Eli Lilly and Company Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Recombinant DNA (rDNA) Technology Product
Table 103. Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 104. Sanofi Recent Development
Table 105. Biocon Company Details
Table 106. Biocon Business Overview
Table 107. Biocon Recombinant DNA (rDNA) Technology Product
Table 108. Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 109. Biocon Recent Development
Table 110. GlaxoSmithKline plc Company Details
Table 111. GlaxoSmithKline plc Business Overview
Table 112. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Product
Table 113. GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 114. GlaxoSmithKline plc Recent Development
Table 115. New England Biolabs. Company Details
Table 116. New England Biolabs. Business Overview
Table 117. New England Biolabs. Recombinant DNA (rDNA) Technology Product
Table 118. New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 119. New England Biolabs. Recent Development
Table 120. Cibus Company Details
Table 121. Cibus Business Overview
Table 122. Cibus Recombinant DNA (rDNA) Technology Product
Table 123. Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 124. Cibus Recent Development
Table 125. Monsanto Company Company Details
Table 126. Monsanto Company Business Overview
Table 127. Monsanto Company Recombinant DNA (rDNA) Technology Product
Table 128. Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 129. Monsanto Company Recent Development
Table 130. Horizon Discovery Group PLC Company Details
Table 131. Horizon Discovery Group PLC Business Overview
Table 132. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Product
Table 133. Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 134. Horizon Discovery Group PLC Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant DNA (rDNA) Technology Market Share by Type: 2020 VS 2027
Figure 2. Expression System Features
Figure 3. Cloning Vector Features
Figure 4. Global Recombinant DNA (rDNA) Technology Market Share by Application: 2020 VS 2027
Figure 5. Biotechnology and Pharmaceutical Companies Case Studies
Figure 6. Academic and Government Research Institutes Case Studies
Figure 7. Other Case Studies
Figure 8. Recombinant DNA (rDNA) Technology Report Years Considered
Figure 9. Global Recombinant DNA (rDNA) Technology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Recombinant DNA (rDNA) Technology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Recombinant DNA (rDNA) Technology Market Share by Regions: 2020 VS 2027
Figure 12. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2022-2027)
Figure 13. Global Recombinant DNA (rDNA) Technology Market Share by Players in 2020
Figure 14. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Recombinant DNA (rDNA) Technology Revenue in 2020
Figure 16. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2016-2021)
Figure 17. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2022-2027)
Figure 18. North America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Recombinant DNA (rDNA) Technology Market Share by Type (2016-2027)
Figure 20. North America Recombinant DNA (rDNA) Technology Market Share by Application (2016-2027)
Figure 21. North America Recombinant DNA (rDNA) Technology Market Share by Country (2016-2027)
Figure 22. United States Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Recombinant DNA (rDNA) Technology Market Share by Type (2016-2027)
Figure 26. Europe Recombinant DNA (rDNA) Technology Market Share by Application (2016-2027)
Figure 27. Europe Recombinant DNA (rDNA) Technology Market Share by Country (2016-2027)
Figure 28. Germany Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Recombinant DNA (rDNA) Technology Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Recombinant DNA (rDNA) Technology Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Recombinant DNA (rDNA) Technology Market Share by Region (2016-2027)
Figure 38. China Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Recombinant DNA (rDNA) Technology Market Share by Type (2016-2027)
Figure 46. Latin America Recombinant DNA (rDNA) Technology Market Share by Application (2016-2027)
Figure 47. Latin America Recombinant DNA (rDNA) Technology Market Share by Country (2016-2027)
Figure 48. Mexico Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Recombinant DNA (rDNA) Technology Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Recombinant DNA (rDNA) Technology Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Recombinant DNA (rDNA) Technology Market Share by Country (2016-2027)
Figure 54. Turkey Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 58. Profacgen Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 59. Amgen Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 60. Novartis AG Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 61. GenScript Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 62. Pfizer Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 63. Novo Nordisk A/S Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 66. Biocon Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 67. GlaxoSmithKline plc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 68. New England Biolabs. Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 69. Cibus Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 70. Monsanto Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 71. Horizon Discovery Group PLC Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---